Related Experiment Videos
[Retrovesical leiomyosarcoma responsive to preoperative chemoradiotherapy: a case report]
Hinyokika Kiyo. Acta Urologica Japonica
|August 1, 1997
Summary
A retrovesical leiomyosarcoma in a 70-year-old man showed significant tumor shrinkage after intraarterial chemotherapy and radiotherapy. This neoadjuvant treatment facilitated successful surgical removal, with no recurrence observed at 12 months.
Area of Science:
- Oncology
- Urology
- Radiotherapy
Background:
- Retrovesical tumors are rare and can present diagnostic challenges.
- Leiomyosarcoma is an uncommon soft tissue sarcoma that can occur in the retrovesical space.
- Multimodality treatment is often necessary for managing large retrovesical tumors.
Observation:
- A 70-year-old male presented with dysuria and was diagnosed with a large retrovesical solid tumor.
- Imaging studies (CT and MRI) confirmed the tumor's size and location.
- Transurethral needle biopsy identified the tumor as leiomyosarcoma.
Findings:
- Neoadjuvant intraarterial chemotherapy (cisplatin, methotrexate, pirarubicin) combined with radiotherapy (40 Gy) significantly reduced tumor size.
- Surgical extirpation was successfully performed following neoadjuvant treatment.
- Postoperative assessment revealed no infiltration into adjacent organs or lymph node metastasis.
Implications:
- This case highlights the efficacy of neoadjuvant intraarterial chemotherapy and radiotherapy for retrovesical leiomyosarcoma.
- A combined treatment approach can facilitate complete surgical resection of challenging retrovesical tumors.
- Successful management led to a 12-month recurrence-free survival, suggesting a favorable prognosis with this strategy.